Transdermal delivery of tadalafil. I. Effect of vehicles on skin permeation.
Transdermal delivery that avoids the presystemic disposition can provide an alternative to oral administration of tadalafil. Accordingly, the aim of this study was to select the best vehicle as the first step in optimization of tadalafil transdermal delivery. The vehicles were used neat or in selected binary combinations and were evaluated for drug solubilization and transdermal delivery. The drug solubility in pure vehicles were ranked as polyethylene glycol (PEG) 400 > propylene glycol (PG) > ethanol > ethyl oleate (EO) > isopropyl myristate (IPM) > water. The solubility in binary systems containing ethanol at 2:1 ratios with EO or IPM was greater than that obtained with pure ethanol, EO, or IPM. This effect could be due to the cosolvency effect. The transdermal drug delivery from pure vehicles was ranked as IPM > EO > ethanol > PG > PEG > water. The delivery from binary mixtures of ethanol with either IPM or EO was higher than that obtained from pure solvents with the delivery increasing with increasing ethanol concentration in the mixtures. The delivery from binary mixtures was synergistic rather than additive. The study thus demonstrated a potential of tadalafil transdermal delivery. Binary combinations of ethanol with either IPM or EO provided the first step forward toward the development of transdermal delivery system for tadalafil.
El Maghraby
Gamal M
GM
Department of Pharmaceutics, College of Pharmacy, Kayyali Chair for Pharmaceutical Industry, King Saud University, Riyadh, Saudi Arabia. gmmelmag@yahoo.com
Alanazi
Fars Kaed
FK
Alsarra
Ibrahim A
IA
D000279:Administration, Cutaneous; D000818:Animals; D002243:Carbolines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000431:Ethanol / Q000737:chemistry; D066298:In Vitro Techniques; D008297:Male; D009226:Myristates / Q000737:chemistry; D009829:Oleic Acids / Q000737:chemistry; D014677:Pharmaceutical Vehicles / Q000737:chemistry*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011817:Rabbits; D012869:Skin Absorption; D012995:Solubility; D000068581:Tadalafil
D002243:Carbolines; D009226:Myristates; D009829:Oleic Acids; D014677:Pharmaceutical Vehicles; D010726:Phosphodiesterase Inhibitors; C008205:isopropyl myristate; D000431:Ethanol; D000068581:Tadalafil; C033180:ethyl oleate